Natroba™ (spinosad) Topical Suspension, 0.9% for head lice1
ParaPRO first commercialized the use of spinosad in Natroba™ Topical Suspension, 0.9% for the treatment of head lice. The product received FDA approval in 2011 and has since become the most widely prescribed product for infestations.1,2 Natroba™ is also available as an Authorized Generic under the name Spinosad Topical Suspension, 0.9% to enhance access to patients and families who are afflicted with this condition.
Learn more about this proven therapy for today’s head lice infestations. Visit natroba.com or spinosadrx.com for the latest evidence-based clinical data and insights from the leading scientific and medical experts.
References: 1. Natroba Prescribing Information. 2. IQVIA – National prescription market share: Head lice,8.31.19 PPO-PPW6-000